Clinical trial Recruiting at 1 site Interventional Ages 0 Months to 6 Months

Probiotic supplement in healthy infants to study gut microbiota and immune function

Official title: Study on the Effects of Lactobacillus Paracasei LPB27 on Infant Gut Microbiota and Immune Regulation

Run by BYHEALTH Co., LTD · NCT07896083 · Data updated 2026-11-12

Giving a probiotic to healthy infants from birth up to 6 months old to see how it affects their gut bacteria and immune health.

More Healthy Infants trials

Quick facts

Study typeInterventional
Ages0 Months to 6 Months
SexAll
Enrollment370 (estimated)
SponsorBYHEALTH Co., LTD
Industry-sponsored
Locations1 site (Dalian, Liaoning)
StatusRecruiting
StartedOctober 11, 2025
Main results expectedJuly 11, 2027
Study endsAugust 25, 2027
Registry record updatedOctober 26, 2026
Trial IDNCT07896083 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are healthy, full-term infants aged 0-6 months whose guardians consent to participate and agree to avoid other probiotics during the study.

Probably not a fit

Infants with significant acute or chronic illnesses or those whose conditions may interfere with normal intestinal development may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study tests the effects of Lacticaseibacillus paracasei LPB27 on gut microbiota composition, growth, and immune-related outcomes in healthy full-term infants aged 0-6 months. The study also looks at defecation patterns and common gastrointestinal symptoms. Participants will receive the probiotic supplement with maltodextrin, with restrictions on other probiotic use during the study. The trial is conducted at Zhongshan Hospital affiliated with Dalian University, sponsored by BYHEALTH Co., Ltd, with no listed collaborators.

Why it matters

Potential benefit: If successful, the probiotic could support healthier gut microbiota and potentially modulate immune development in infancy.

How similar studies have gone: Previous probiotic studies in infants have shown microbiota and GI symptom modulation with certain strains, but outcomes are strain-specific and context-dependent.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. Infants born at full term and aged 0-6 months, whose overall health condition was determined to be good by the researchers;
* 2\. There are no restrictions on the mode of delivery and feeding methods;
* 3\. Agree not to consume probiotics other than the tested product or formula milk powder containing probiotics during the study period;
* 4\. Parents or legal guardians voluntarily participate in this clinical trial and sign the informed consent form.

Exclusion Criteria:

* 1\. Suffering from severe acute or chronic coexisting diseases (cardiovascular, gastrointestinal, metabolic, endocrine, immune or any disease deemed contraindicated by the researchers);
* 2\. Having a disease that might interfere with the researcher's observation of the normal development process of the infant's intestinal microecology. Such diseases include: acute infections (acute upper respiratory tract infection, acute diarrhea, etc.); autoimmune diseases (such as ulcerative colitis, Crohn's disease, etc.); intestinal surgeries (intussusception, intestinal obstruction, endoscopic examination, etc.), major surgeries (post-surgery for congenital heart disease, etc.), genetic metabolic diseases (such as cystic fibrosis), burns and severe trauma, energy metabolism-related diseases (diabetes, cerebral palsy, etc.), premature birth, tumors, diseases with abnormal intestinal structure development (megacolon, gastric torsion, etc.);
* 3\. Having consumed probiotics or formula milk containing probiotics in the past two weeks;
* 4\. Having used antibiotics in the past two months;
* 5\. Having participated in drug clinical research in the past three months;
* 6\. Refusing random grouping.

Where it's running

  • Zhongshan Hospital Affiliated to Dalian University
    Dalian, Liaoning, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.